SCHEMBL23641683

SCHEMBL23641683

O=P(O)(S)OC[C@@H]1CC[C@H](n2cc3c4c(ncnc42)NCCC3)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23641755 0.91 CASP6 (0.31) —
SCHEMBL24861152 0.84 — —
SCHEMBL23641851 0.84 CASP6 (0.32) —
SCHEMBL24191244 0.83 ALDH1A1 (0.40) —
SCHEMBL23641868 0.82 — —
SCHEMBL23641845 0.81 P2RX3 (0.44) —
SCHEMBL23641750 0.79 P2RY2 (0.36) —
SCHEMBL23641810 0.79 RNASEL (0.41) —
SCHEMBL20224842 0.71 ALDH1A1 (0.45) —
SCHEMBL20224899 0.71 ALDH1A1 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3848054-A1 NOVEL CYCLIC DINUCLEOTIDE DERIVATIVE AND ANTIBODY-DRUG CONJUGATE THEREOF Daiichi Sankyo Company, Limited (JP) 2021-07-14 — — EP disclosed
Send feedback